Bureau De Change (BDC) operators have commenced discussions on mergers and acquisition in order to meet the recapitalisation ...

Moleculin Biotech (MBRX) has received first country regulatory approval in Europe to begin recruiting for its Phase 3 pivotal trial protocol ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

CrossFi has passed a rigorous Anti-Money Laundering (AML) audit conducted by the esteemed advisory firm, CityLinkers.

Mikkael A. Sekeres, MD, Sylvester Comprehensive Cancer Center, discusses the potential benefits of treosulfan, a newly ...

Dana-Farber Cancer Institute researchers have identified factors that determine whether donor lymphocyte infusion (DLI), a standard therapy for patients with acute myeloid leukemia (AML ...

Acute myeloid leukaemia (AML) is mainly characterized by an increase in the number of myeloid cells in the bone marrow and a decrease in mature cells, accounting for 28% of leukaemia cases ...

The Food and Drug Administration (FDA) has approved Grafapex ™ (treosulfan ... aged 1 year and older with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). Findings showed OS ...

Opens in a new tab or window The FDA approved treosulfan (Grafapex ... patients ages 1 year and older with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS), Medexus announced ...